|
Prowse, Amanda H; Vanderveer, Lisa; Milling, Simon W F et al. (2002) OVCA2 is downregulated and degraded during retinoid-induced apoptosis. Int J Cancer 99:185-92
|
|
Rebbeck, T R; Wang, Y; Kantoff, P W et al. (2001) Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res 61:5420-4
|
|
Bruening, W; Giasson, B I; Klein-Szanto, A J et al. (2000) Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88:2154-63
|
|
Kulinski, J; Besack, D; Oleykowski, C A et al. (2000) CEL I enzymatic mutation detection assay. Biotechniques 29:44-6, 48
|
|
Grobelny, J V; Godwin, A K; Broccoli, D (2000) ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. J Cell Sci 113 Pt 24:4577-85
|
|
Salicioni, A M; Xi, M; Vanderveer, L A et al. (2000) Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor. Genomics 69:54-62
|
|
Riccio, A; Aaltonen, L A; Godwin, A K et al. (1999) The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 23:266-8
|
|
Dangel, J; Wagner-Costalas, J; Bove, B et al. (1999) Novel germline BRCA1 mutation (155del4) in an African American with early-onset breast cancer. Hum Mutat 14:545
|
|
Bruening, W; Prowse, A H; Schultz, D C et al. (1999) Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. Cancer Res 59:4973-83
|
|
Oleykowski, C A; Bronson Mullins, C R; Godwin, A K et al. (1998) Mutation detection using a novel plant endonuclease. Nucleic Acids Res 26:4597-602
|
Showing the most recent 10 out of 11 publications
